Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Government urges universal flu vaccinations

24.08.2010
The flu kills more than 35,000 people in the United States in an average year—and most of those deaths could be prevented with a simple vaccine. After last year’s H1N1 outbreak, the government says everyone over the age of 6 months needs a flu shot this year.
Flu vaccine will soon be available at local pharmacies and doctor’s offices, and government officials are urging everyone over 6 months of age to receive it. This year’s vaccine protects against H1N1 and two other strains of seasonal flu.

The recommendation represents a break from past years, when the government focused on vaccinating people in certain “high-risk” groups and those in contact with people at high risk.

“The message is simple now,” said David Weber, MD, MPH, professor of medicine, pediatrics and epidemiology at the University of North Carolina at Chapel Hill. “If you’re more than 6 months of age, get the vaccine.”

“In an average year, there are more than 200,000 hospitalizations and more than 35,000 deaths from flu. Many of those would be preventable by simply getting the flu shot,” said Weber. “Flu shots are far and away the best way for preventing flu.”

The Advisory Committee on Immunization Practices, a Centers for Disease Control and Prevention (CDC) advisory panel that set the recommendation for universal vaccination cited last year’s H1N1 outbreak—which affected many young, healthy people not traditionally considered to be at high risk for complications from flu—as part of the reason for the change. In addition, the list of conditions that put a person at high risk has grown so much over the years that many people are unaware of their high-risk status. Universal vaccination is expected to better protect individuals and the population as a whole.

People should receive the vaccine every year as soon as it becomes available, said Weber. “It’s important every year. This year it may be more important because anybody who didn’t get H1N1 last year is susceptible to it, and since that was the first year H1N1 was around, many people, if not most people, are susceptible.”

The vaccine is reformulated each year to provide protection against the virus strains that present the greatest public health threat for that year. People who contracted H1N1 last year may have a lower chance of contracting it again this year, but they should still receive the vaccine for protection against seasonal flu.

Adults need only one dose of the vaccine. Children 6 months to 8 years old may need two doses, depending on which vaccines they received last year.

The vaccine will be available at doctor’s offices and at many pharmacies as both a nasal spray and as a shot. The shot is recommended for people younger than 2 or older than 49, and people with a suppressed immune system. The nasal spray is appropriate for most other healthy people.

Les Lang | EurekAlert!
Further information:
http://www.cdc.gov/flu

More articles from Health and Medicine:

nachricht NTU scientists build new ultrasound device using 3-D printing technology
07.12.2016 | Nanyang Technological University

nachricht How to turn white fat brown
07.12.2016 | University of Pennsylvania School of Medicine

All articles from Health and Medicine >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Significantly more productivity in USP lasers

In recent years, lasers with ultrashort pulses (USP) down to the femtosecond range have become established on an industrial scale. They could advance some applications with the much-lauded “cold ablation” – if that meant they would then achieve more throughput. A new generation of process engineering that will address this issue in particular will be discussed at the “4th UKP Workshop – Ultrafast Laser Technology” in April 2017.

Even back in the 1990s, scientists were comparing materials processing with nanosecond, picosecond and femtosesecond pulses. The result was surprising:...

Im Focus: Shape matters when light meets atom

Mapping the interaction of a single atom with a single photon may inform design of quantum devices

Have you ever wondered how you see the world? Vision is about photons of light, which are packets of energy, interacting with the atoms or molecules in what...

Im Focus: Novel silicon etching technique crafts 3-D gradient refractive index micro-optics

A multi-institutional research collaboration has created a novel approach for fabricating three-dimensional micro-optics through the shape-defined formation of porous silicon (PSi), with broad impacts in integrated optoelectronics, imaging, and photovoltaics.

Working with colleagues at Stanford and The Dow Chemical Company, researchers at the University of Illinois at Urbana-Champaign fabricated 3-D birefringent...

Im Focus: Quantum Particles Form Droplets

In experiments with magnetic atoms conducted at extremely low temperatures, scientists have demonstrated a unique phase of matter: The atoms form a new type of quantum liquid or quantum droplet state. These so called quantum droplets may preserve their form in absence of external confinement because of quantum effects. The joint team of experimental physicists from Innsbruck and theoretical physicists from Hannover report on their findings in the journal Physical Review X.

“Our Quantum droplets are in the gas phase but they still drop like a rock,” explains experimental physicist Francesca Ferlaino when talking about the...

Im Focus: MADMAX: Max Planck Institute for Physics takes up axion research

The Max Planck Institute for Physics (MPP) is opening up a new research field. A workshop from November 21 - 22, 2016 will mark the start of activities for an innovative axion experiment. Axions are still only purely hypothetical particles. Their detection could solve two fundamental problems in particle physics: What dark matter consists of and why it has not yet been possible to directly observe a CP violation for the strong interaction.

The “MADMAX” project is the MPP’s commitment to axion research. Axions are so far only a theoretical prediction and are difficult to detect: on the one hand,...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

ICTM Conference 2017: Production technology for turbomachine manufacturing of the future

16.11.2016 | Event News

Innovation Day Laser Technology – Laser Additive Manufacturing

01.11.2016 | Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

 
Latest News

NTU scientists build new ultrasound device using 3-D printing technology

07.12.2016 | Health and Medicine

The balancing act: An enzyme that links endocytosis to membrane recycling

07.12.2016 | Life Sciences

How to turn white fat brown

07.12.2016 | Health and Medicine

VideoLinks
B2B-VideoLinks
More VideoLinks >>>